BACKGROUND: The complement system is tightly controlled by several regulators. Two of these, factor H (FH) and C4b-binding protein (C4BP), can be acquired by pathogens conveying resistance to complement attack. The aim of the study was to characterize the FH binding molecule of Candida albicans, a potentially life-threatening yeast. METHODS: The gene coding for this molecule was identified by probing an expression library and homozygous deletion mutants of the respective gene were constructed. Binding and functional assays were undertaken to compare wild-type and knockout strains. RESULTS: The high-affinity glucose transporter 1 (CaHgt1p) was identified as an FH-binding molecule. Homozygous hgt1Δ/Δ deletion mutants, but not the restored strain in which HGT1 was reintegrated, showed a decreased binding of FH and even of C4BP, demonstrating its function as an FH- and C4BP-binding protein. This led to an enhanced terminal complement complex deposition after incubation with human serum; CaHgt1p thus functions as complement inhibitor. hgt1Δ/Δ mutants failed to form rosettes with complement-coated sheep erythrocytes, and show reduced binding to HIV-gp160, implying that a complement receptor 3 (CR3) moiety, known as fungal HIV binding molecule is lacking. CONCLUSIONS: CaHgt1p is a multifunctional evasion molecule, as complement inhibitor, CR3 analogue and HIV receptor.
BACKGROUND: The complement system is tightly controlled by several regulators. Two of these, factor H (FH) and C4b-binding protein (C4BP), can be acquired by pathogens conveying resistance to complement attack. The aim of the study was to characterize the FH binding molecule of Candida albicans, a potentially life-threatening yeast. METHODS: The gene coding for this molecule was identified by probing an expression library and homozygous deletion mutants of the respective gene were constructed. Binding and functional assays were undertaken to compare wild-type and knockout strains. RESULTS: The high-affinity glucose transporter 1 (CaHgt1p) was identified as an FH-binding molecule. Homozygous hgt1Δ/Δ deletion mutants, but not the restored strain in which HGT1 was reintegrated, showed a decreased binding of FH and even of C4BP, demonstrating its function as an FH- and C4BP-binding protein. This led to an enhanced terminal complement complex deposition after incubation with human serum; CaHgt1p thus functions as complement inhibitor. hgt1Δ/Δ mutants failed to form rosettes with complement-coated sheep erythrocytes, and show reduced binding to HIV-gp160, implying that a complement receptor 3 (CR3) moiety, known as fungal HIV binding molecule is lacking. CONCLUSIONS: CaHgt1p is a multifunctional evasion molecule, as complement inhibitor, CR3 analogue and HIV receptor.
Authors: E Lukasser-Vogl; A Gruber; C Lass-Flörl; A Eder; A K Høgåsen; B P Morgan; M P Dierich; R Würzner Journal: FEMS Immunol Med Microbiol Date: 2000-05
Authors: Elvira Marín; Claudia M Parra-Giraldo; Carolina Hernández-Haro; María L Hernáez; César Nombela; Lucía Monteoliva; Concha Gil Journal: Front Microbiol Date: 2015-12-08 Impact factor: 5.640
Authors: Caroline M Marcos; Haroldo C de Oliveira; Wanessa de Cássia M Antunes de Melo; Julhiany de Fátima da Silva; Patrícia A Assato; Liliana Scorzoni; Suélen A Rossi; Ana C A de Paula E Silva; Maria J S Mendes-Giannini; Ana M Fusco-Almeida Journal: Front Cell Infect Microbiol Date: 2016-11-15 Impact factor: 5.293
Authors: Crisanto M Lopez; Reinhard Wallich; Kristian Riesbeck; Christine Skerka; Peter F Zipfel Journal: PLoS One Date: 2014-03-13 Impact factor: 3.240